3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
22
Neoplasms
13
Breast Neoplasms
9
Lung Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Peripheral Nervous System Diseases
2
Obesity
2
Neoplasm Metastasis
2
Lymphoma
2
Lymphedema
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcopenia
1
Rectal Neoplasms
1
Quality of Life
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Neurotoxicity Syndromes
1
Neurocognitive Disorders
1
Neoplasms, Plasma Cell
1
Muscular Atrophy
1
Multiple Myeloma
1
Interventions
Cyclophosphamide
45
fludarabine
32
Methotrexate
24
blinatumomab
20
Vincristine
19
Dexamethasone
19
fludarabine phosphate
18
Specimen Handling
17
Cytarabine
17
Whole-Body Irradiation
14
Melphalan
13
Tacrolimus
12
Calcium Dobesilate
12
Biopsy
12
Mercaptopurine
11
Busulfan
11
merphos
10
Peripheral Blood Stem Cell Transplantation
10
Mycophenolic Acid
10
Thiotepa
9
Stem Cell Transplantation
9
Rituximab
9
Granulocyte Colony-Stimulating Factor
9
Doxorubicin
9
venetoclax
8
ponatinib
8
dexamethasone acetate
8
dexamethasone 21-phosphate
8
Prednisone
8
Mesna
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Exercise
×
90 days
×
Clear all
NCT07325305
2026-04-13
PROTECT
Murdoch Childrens Research Institute
Phase NA
Recruiting
60 enrolled